26
20
Brain Tumor Reports

Volume 11 Number 12
December 2011

Home > Publications > Brain Tumor Reports > Volume 11, Year 2011 > Number 12, December°


Contents




Classification



Deangelis LM, Mellinghoff IK.
Virchow 2011 or How to ID(H) Human Glioblastoma.
J Clin Oncol. 2011 Oct 24;. [Epub ahead of print]
 
Abstract |   Reprint |   Related articles

Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS.
Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin.
J Clin Oncol. 2011 Oct 24;. [Epub ahead of print]
 
Abstract |   Related articles


Diagnosis



Gonzalez-Segura A, Morales JM, Gonzalez-Darder JM, Cardona-Marsal R, Lopez-Gines C, Cerda-Nicolas M, Monleon D.
Magnetic resonance microscopy at 14 tesla and correlative histopathology of human brain tumor tissue.
PLoS One. 2011;6(11):e27442.
 
Abstract |   Reprint |   Related articles

Li WB, Tang K, Zhang W, Yan W, You G, Li SW, Zhang L, Huang YJ, Jiang T.
Relationship between magnetic resonance imaging and molecular pathology in patients with glioblastoma multiforme.
Chin Med J (Engl). 2011 Sep;124(17):2589-92.
 
Abstract |   Reprint |   Related articles


Epidemiology



Frei P, Poulsen AH, Johansen C, Olsen JH, Steding-Jessen M, Schüz J.
Use of mobile phones and risk of brain tumours: update of Danish cohort study.
BMJ. 2011 Oct 19;343:d6387.
 
Abstract |   Reprint |   Related articles


Etiology & Pathogenesis



Cobbs CS.
Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis.
Herpesviridae. 2011 Oct 26;2(1):10. [Epub ahead of print]
 
Abstract |   Reprint |   Related articles

Pellegatta S, Cuppini L, Finocchiaro G.
Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas.
Expert Rev Anticancer Ther. 2011 Nov;11(11):1759-74.
 
Abstract |   Related articles

Song X, Andrew Allen R, Terence Dunn S, Fung KM, Farmer P, Gandhi S, Ranjan T, Demopoulos A, Symons M, Schulder M, Li JY.
Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma.
Int J Clin Exp Pathol. 2011;4(7):651-60. Epub 2011 Sep 17.
 
Abstract |   Reprint |   Related articles

Utsuki S, Oka H, Miyajima Y, Kijima C, Yasui Y, Fujii K.
Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma.
Brain Tumor Pathol. 2011 Nov 11;. [Epub ahead of print]
 
Abstract |   Related articles


Integrative Medicine



Scheck AC, Abdelwahab MG, Fenton KE, Stafford P.
The ketogenic diet for the treatment of glioma: Insights from genetic profiling.
Epilepsy Res. 2011 Oct 21;. [Epub ahead of print]
 
Abstract |   Related articles


Overall Management



Brandes AA, Franceschi E, Gorlia T, Wick W, Jacobs AH, Baumert BG, van den Bent M, Weller M, Stupp R.
Appropriate end-points for right results in the age of antiangiogenic agents: Future options for phase II trials in patients with recurrent glioblastoma.
Eur J Cancer. 2011 Nov 23;. [Epub ahead of print]
 
Abstract |   Related articles

Jiao Y, Berman H, Kiehl TR, Torquato S.
Spatial organization and correlations of cell nuclei in brain tumors.
PLoS One. 2011;6(11):e27323. Epub 2011 Nov 16.
 
Abstract |   Reprint |   Related articles

Persano L, Rampazzo E, Della Puppa A, Pistollato F, Basso G.
The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications.
ScientificWorldJournal. 2011;11:1829-41. Epub 2011 Oct 23.
 
Abstract |   Reprint |   Related articles


Prognosis



Johnson DR, O'Neill BP.
Glioblastoma survival in the United States before and during the temozolomide era.
J Neurooncol. 2011 Nov 2;. [Epub ahead of print]
 
Abstract |   Related articles


Stem Cells



Chamberlain MC, Bota DA, Linskey ME, Schwartz PH.
Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.
Neurology. 2011 Nov 29;77(22):e135-6.
 
Abstract |   Full text |   Related articles

Matos Rojas IA, Bertholdo D, Castillo M.
Stem cells: implications in the development of brain tumors.
Radiologia. 2011 Nov 23;. [Epub ahead of print]. Spanish
 
Abstract |   Reprint |   Related articles


Treatment


Laboratory Investigations



Bikfalvi A, Moenner M, Javerzat S, North S, Hagedorn M.
Inhibition of angiogenesis and the angiogenesis/invasion shift.
Biochem Soc Trans. 2011 Dec 1;39(6):1560-4.
 
Abstract |   Related articles

Nieto-Sampedro M, Valle-Argos B, Gómez-Nicola D, Fernández-Mayoralas A, Nieto-Díaz M.
Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.
Clin Med Insights Oncol. 2011;5:265-314. Epub 2011 Sep 21.
 
Abstract |   Reprint |   Related articles

Van Nifterik KA, Van den Berg J, Slotman BJ, Lafleur MV, Sminia P, Stalpers LJ.
Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation.
J Neurooncol. 2011 Oct 26;. [Epub ahead of print]
 
Abstract |   Related articles


Clinical Investigations



Chinnaiyan P, Chowdhary S, Potthast L, Prabhu A, Tsai YY, Sarcar B, Kahali S, Brem S, Yu HM, Rojiani A, Murtagh R, Pan E.
Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma.
Neuro Oncol. 2011 Oct 25;. [Epub ahead of print]
 
Abstract |   Related articles

Cho DY, Yang WK, Lee HC, Hsu DM, Lin HL, Lin SZ, Chen CC, Harn HJ, Liu CL, Lee WY, Ho LH.
Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial.
World Neurosurg. 2011 Nov 7;. [Epub ahead of print]
 
Abstract |   Related articles

Finocchiaro G, Pellegatta S.
Immunotherapy for glioma: getting closer to the clinical arena?
Curr Opin Neurol. 2011 Dec;24(6):641-7.
 
Abstract |   Related articles

Friday BB, Anderson SK, Buckner J, Yu C, Giannini C, Geoffroy F, Schwerkoske J, Mazurczak M, Gross H, Pajon E, Jaeckle K, Galanis E.
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.
Neuro Oncol. 2011 Nov 16;. [Epub ahead of print]
 
Abstract |   Related articles

Franceschi E, Agati R, Brandes AA.
End points for Phase II trials in recurrent glioblastoma: the cornerstone for a new era.
Expert Rev Anticancer Ther. 2011 Nov;11(11):1713-7.
 
Abstract |   Related articles

Freyschlag CF, Smolczyk DR, Janzen E, Schmieder K, Thomé C, Lohr F, Wenz F, Weiss C, Tuettenberg J, Seiz M.
Prolonged administration of temozolomide in adult patients with anaplastic glioma.
Anticancer Res. 2011 Nov;31(11):3873-7.
 
Abstract |   Related articles

Giglio P, Dhamne M, Hess KR, Gilbert MR, Groves MD, Levin VA, Kang SL, Ictech SE, Liu V, Colman H, Conrad CA, Loghin M, de Groot J, Yung WK, Puduvalli VK.
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.
Cancer. 2011 Nov 15;. [Epub ahead of print]
 
Abstract |   Related articles

Lam N, Chambers CR.
Temozolomide plus radiotherapy for glioblastoma in a Canadian province: Efficacy versus effectiveness and the impact of O6-methylguanine-DNA-methyltransferase promoter methylation.
J Oncol Pharm Pract. 2011 Nov 7;. [Epub ahead of print]
 
Abstract |   Related articles

Lorgis V, Maura G, Coppa G, Hassani K, Taillandier L, Chauffert B, Apetoh L, Ladoire S, Ghiringhelli F.
Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts.
J Neurooncol. 2011 Nov 11;. [Epub ahead of print]
 
Abstract |   Related articles

Mason WP, Belanger K, Nicholas G, Vallières I, Mathieu D, Kavan P, Desjardins A, Omuro A, Reymond D.
A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression.
J Neurooncol. 2011 Nov 3;. [Epub ahead of print]
 
Abstract |   Related articles

Minniti G, Lanzetta G, Scaringi C, Caporello P, Salvati M, Arcella A, De Sanctis V, Giangaspero F, Enrici RM.
Phase II Study of Short-Course Radiotherapy plus Concomitant and Adjuvant Temozolomide in Elderly Patients with Glioblastoma.
Int J Radiat Oncol Biol Phys. 2011 Nov 11;. [Epub ahead of print]
 
Abstract |   Related articles

Narayana A, Gruber D, Kunnakkat S, Golfinos JG, Parker E, Raza S, Zagzag D, Eagan P, Gruber ML.
A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma.
J Neurosurg. 2011 Oct 28;. [Epub ahead of print]
 
Abstract |   Related articles

Niewald M, Berdel C, Fleckenstein J, Licht N, Ketter R, Rübe C.
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation.
Radiat Oncol. 2011 Oct 21;6:141.
 
Abstract |   Reprint |   Related articles

Ohno M, Narita Y, Miyakita Y, Ueno H, Kayama T, Shibui S.
Reactivation of hepatitis B virus after glioblastoma treatment with temozolomide.
Neurol Med Chir (Tokyo). 2011;51(10):728-31. Release Date: October 25, 2011.
 
Abstract |   Reprint |   Related articles

Pouleau HB, Sadeghi N, Balériaux D, Mélot C, De Witte O, Lefranc F.
High levels of cellular proliferation predict pseudoprogression in glioblastoma patients.
Int J Oncol. 2011 Nov 11;. [Epub ahead of print]
 
Abstract |   Reprint |   Related articles

Park KJ, Kano H, Iyer A, Liu X, Niranjan A, Flickinger JC, Lieberman FS, Lunsford LD, Kondziolka D.
Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study.
J Neurooncol. 2011 Nov 5;. [Epub ahead of print]
 
Abstract |   Related articles

Reardon DA, Wen PY, Alfred Yung WK, Berk L, Narasimhan N, Turner CD, Clackson T, Rivera VM, Vogelbaum MA.
Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial.
Cancer Chemother Pharmacol. 2011 Oct 30;. [Epub ahead of print]
 
Abstract |   Related articles

Shahar T, Ram Z, Kanner AA.
Convection-enhanced delivery catheter placements for high-grade gliomas: complications and pitfalls.
J Neurooncol. 2011 Nov 4;. [Epub ahead of print]
 
Abstract |   Related articles

Sorensen AG, Emblem KE, Polaskova P, Jennings D, Kim H, Ancukiewicz M, Wang M, Wen PY, Ivy P, Batchelor TT, Jain RK.
Increased Survival of Glioblastoma Patients who Respond to Anti-angiogenic Therapy with Elevated Blood Perfusion.
Cancer Res. 2011 Nov 29. [Epub ahead of print]
 
Abstract

Tsien CI, Brown D, Normolle D, Schipper M, Morand P, Junck L, Heth JA, Gomez-Hassan D, Ten-Haken R, Chenevert TL, Cao Y, Lawrence TS.
Concurrent Temozolomide and Dose-Escalated Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma.
Clin Cancer Res. 2011 Nov 7;. [Epub ahead of print]
 
Abstract |   Related articles

White E, Bienemann A, Taylor H, Hopkins K, Cameron A, Gill S.
A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme.
Contemp Clin Trials. 2011 Nov 12;. [Epub ahead of print]
 
Abstract |   Related articles


Treatment Overviews



Clarke J, Butowski N, Chang S.
Recent advances in therapy for glioblastoma.
Arch Neurol. 2010 Mar;67(3):279-83.
 
Abstract |   Reprint |   Related articles